These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34645285)

  • 1. Frequency and Prognostic Significance of Clinical Fluctuations Before Hospital Arrival in Stroke.
    Romano JG; Gardener H; Smith EE; Campo-Bustillo I; Khan Y; Tai S; Riley N; Sacco RL; Khatri P; Alger HM; Mac Grory B; Gulati D; Sangha NS; Olds KE; Benesch CG; Kelly AG; Brehaut SS; Kansara AC; Schwamm LH;
    Stroke; 2022 Feb; 53(2):482-487. PubMed ID: 34645285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS.
    Romano JG; Gardener H; Campo-Bustillo I; Khan Y; Tai S; Riley N; Smith EE; Sacco RL; Khatri P; Alger HM; Mac Grory B; Gulati D; Sangha NS; Craig JM; Olds KE; Benesch CG; Kelly AG; Brehaut SS; Kansara AC; Schwamm LH;
    Stroke; 2021 Jun; 52(6):1995-2004. PubMed ID: 33947209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.
    Ahmed HK; Logallo N; Thomassen L; Novotny V; Mathisen SM; Kurz MW
    Acta Neurol Scand; 2020 Nov; 142(5):475-479. PubMed ID: 32511749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramedic Global Impression of Change During Prehospital Evaluation and Transport for Acute Stroke.
    Shkirkova K; Schuberg S; Balouzian E; Starkman S; Eckstein M; Stratton S; Pratt FD; Hamilton S; Sharma L; Liebeskind DS; Conwit R; Saver JL; Sanossian N;
    Stroke; 2020 Mar; 51(3):784-791. PubMed ID: 31955642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Tenecteplase Before Thrombectomy for Ischemic Stroke.
    Gao L; Moodie M; Mitchell PJ; Churilov L; Kleinig TJ; Yassi N; Yan B; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Stroke; 2020 Dec; 51(12):3681-3689. PubMed ID: 33023423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streamlining Acute Stroke Care by Introducing National Institutes of Health Stroke Scale in the Emergency Medical Services: A Prospective Cohort Study.
    Larsen K; Jæger HS; Hov MR; Thorsen K; Solyga V; Lund CG; Bache KG
    Stroke; 2022 Jun; 53(6):2050-2057. PubMed ID: 35291821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion: Analysis of the SELECT Cohort Study.
    Sarraj A; Grotta J; Albers GW; Hassan AE; Blackburn S; Day A; Sitton C; Abraham M; Cai C; Dannenbaum M; Pujara D; Hicks W; Budzik R; Vora N; Arora A; Alenzi B; Tekle WG; Kamal H; Mir O; Barreto AD; Lansberg M; Gupta R; Martin-Schild S; Savitz S; Tsivgoulis G;
    Neurology; 2021 Jun; 96(23):e2839-e2853. PubMed ID: 33875560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.
    Agarwal S; Scher E; Lord A; Frontera J; Ishida K; Torres J; Rostanski S; Mistry E; Mac Grory B; Cutting S; Burton T; Silver B; Liberman AL; Lerario MP; Furie K; Grotta J; Khatri P; Saver J; Yaghi S
    Stroke; 2020 Apr; 51(4):1226-1230. PubMed ID: 32102629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
    Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
    Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke.
    Lee EJ; Kim SJ; Bae J; Lee EJ; Kwon OD; Jeong HY; Kim Y; Jeong HB
    PLoS One; 2021; 16(3):e0247829. PubMed ID: 33765030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Neurological Improvement in Inpatient Acute Ischemic Stroke Survivors: A Propensity Score Matching Analysis.
    Wu Q; Tang AJ; Zeng L; Niu SZ; Tian MM; Jin AP; Yang HY; Chen JJ; Xiao-Ping Z; Shi Y
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105437. PubMed ID: 33197800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS Studies.
    Asdaghi N; Romano JG; Gardener H; Campo-Bustillo I; Purdon B; Khan YM; Gulati D; Broderick JP; Schwamm LH; Smith EE; Saver JL; Sacco R; Khatri P
    Stroke; 2021 Oct; 52(10):e586-e589. PubMed ID: 34496619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
    Qureshi AI; Kirmani JF; Sayed MA; Safdar A; Ahmed S; Ferguson R; Hershey LA; Qazi KJ;
    Neurology; 2005 Jun; 64(12):2115-20. PubMed ID: 15985583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.